KRAS and colorectal carcinoma: They suggest that fibroblast-secreted factors can mitigate the effects of KRAS silencing on stem cell marker levels in the membrane of CRC cells, thus unveiling another layer of intricacy in the interplay between KRAS signaling and fibroblasts.